Graham Capital Management, L.P. Provention Bio, Inc. Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.62 $274,959 - $450,516
80,163 New
80,163 $360,000
Q2 2022

Aug 15, 2022
SELL
$3.65 - $7.3 $135,269 - $270,538
-37,060 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$3.4 - $7.88 $56,042 - $129,886
16,483 Added 80.1%
37,060 $271,000
Q4 2021

Feb 14, 2022
BUY
$5.59 - $7.39 $115,025 - $152,064
20,577 New
20,577 $115,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email